thymoquinone has been researched along with on 01910 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DX; Huang, J; Jiang, C; Liu, M | 1 |
| Archambault, V; Normandin, K | 1 |
2 other study(ies) available for thymoquinone and on 01910
| Article | Year |
|---|---|
Identification of indole-3-carboxylic acids as non-ATP-competitive Polo-like kinase 1 (Plk1) inhibitors.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle Proteins; HeLa Cells; Humans; Indoles; MCF-7 Cells; Polo-Like Kinase 1; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Structure-Activity Relationship | 2015 |
Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylators.
Topics: Alkylation; Antineoplastic Agents; Benzoates; Benzoquinones; Cell Cycle Proteins; Glycine; Humans; Mitosis; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Quinones; Sulfones | 2017 |